A Cns-Permeable Hsp90 Inhibitor Rescues Synaptic Dysfunction and Memory Loss in App-Overexpressing Alzheimer'S Mouse Model Via an Hsf1-Mediated Mechanism

B Wang,Y Liu,L Huang,J Chen,J,R Wang,E Kim,Y Chen,C Justicia,K Sakata,H Chen,A Planas,R S Ostrom,W Li,G Yang,M P McDonald,R Chen,D H Heck,F-F Liao
DOI: https://doi.org/10.1038/mp.2016.104
IF: 11
2016-01-01
Molecular Psychiatry
Abstract:Induction of neuroprotective heat-shock proteins via pharmacological Hsp90 inhibitors is currently being investigated as a potential treatment for neurodegenerative diseases. Two major hurdles for therapeutic use of Hsp90 inhibitors are systemic toxicity and limited central nervous system permeability. We demonstrate here that chronic treatment with a proprietary Hsp90 inhibitor compound (OS47720) not only elicits a heat-shock-like response but also offers synaptic protection in symptomatic Tg2576 mice, a model of Alzheimer's disease, without noticeable systemic toxicity. Despite a short half-life of OS47720 in mouse brain, a single intraperitoneal injection induces rapid and long-lasting (>3 days) nuclear activation of the heat-shock factor, HSF1. Mechanistic study indicates that the remedial effects of OS47720 depend upon HSF1 activation and the subsequent HSF1-mediated transcriptional events on synaptic genes. Taken together, this work reveals a novel role of HSF1 in synaptic function and memory, which likely occurs through modulation of the synaptic transcriptome.
What problem does this paper attempt to address?